12/11/2024
4:32 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
6:07 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:11 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:21 PM | Erste Asset Management GmbH (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13G/A | |
11/13/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/02/2024
3:41 PM | Cale Edgar B. (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:51 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
5:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:36 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
7:38 PM | ORBIMED CAPITAL LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:15 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:06 PM | Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
08/09/2024
4:11 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/09/2024
4:15 PM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G/A | |
08/08/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:01 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
3:35 PM | Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
05/23/2024
4:43 PM | Countouriotis Athena (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:51 PM | Passage Bio (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:52 PM | Passage Bio (Issuer)
Sondhi Dolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:53 PM | Islam Saqib (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:55 PM | Kapadia Sandip (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:56 PM | GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:15 AM | Passage Bio (Filer)
| Form 424B3 | |
05/14/2024
6:01 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024
11:15 PM | Passage Bio (Filer)
| Form EFFECT | |
04/12/2024
4:35 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SC 13D/A | |
04/09/2024
8:35 AM | Passage Bio (Filer)
| Form DEFA14A | |
04/09/2024
5:00 AM | Passage Bio (Filer)
| Form ARS | |
04/09/2024
5:02 AM | Passage Bio (Filer)
| Form DEF 14A | |
03/29/2024
3:15 PM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G | |
03/04/2024
6:15 AM | Passage Bio (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
6:02 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:06 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
02/14/2024
8:21 AM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G/A | |
02/13/2024
6:34 PM | Forman Mark S (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:36 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:15 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
6:05 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
